Updated Jul 16, 2026
Donnelly Brian J has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Brian J. Donnelly is the Chief Commercial Officer at Myriad Genetics Inc., a company specializing in genetic testing and precision medicine. He has extensive experience in the biotechnology and pharmaceutical industries, focusing on commercial strategy and market development.
| Role | Chief Commerical Officer |
|---|---|
| Notability | 60/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | MYGN | MYRIAD GENETICS INC | A — Grant or award | 5.0K | $3.94 | $20K |
| 2026-05-04 | MYGN | MYRIAD GENETICS INC | F — Tax withholding / forfeiture | 56.0K | $4.80 | $269K |
| 2026-03-16 | MYGN | MYRIAD GENETICS INC | A — Grant or award | 226.8K | $0.00 |
Brian J. Donnelly is the Chief Commercial Officer at Myriad Genetics Inc., a company specializing in genetic testing and precision medicine. He has extensive experience in the biotechnology and pharmaceutical industries, focusing on commercial strategy and market development.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Donnelly Brian J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.